Phase 2 Triple Negative Breast Cancer (TNBC) trials recruiting now

All Triple Negative Breast Cancer (TNBC) trials, every phase

Other phases for Triple Negative Breast Cancer (TNBC)

Phase 2 Triple Negative Breast Cancer (TNBC) trials

• A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)
  NCT07743190 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)
  NCT07208149 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
  NCT05706129 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 40 locations
• All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer：a Multi-center, Multi-cohort Phase II Trial
  NCT06636981 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 2 locations
• Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer
  NCT06768931 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 5 locations
• BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC
  NCT06793332 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Circadian Rhythm Impact on TNBC Response to Neoadjuvant Immunotherapy
  NCT06880029 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)
  NCT07486089 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC)
  NCT06189209 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 9 locations
• Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
  NCT05582499 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
  NCT05490472 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.
  NCT07394387 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer
  NCT03740893 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
  NCT07069595 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
  NCT06649331 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
  NCT07276880 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer
  NCT07342283 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
  NCT05985655 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 30 locations
• The Optimal Radioimmunotherapy Combinations for Advanced TNBC
  NCT06735131 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.